Legend Biotech Corp at JPMorgan Healthcare Conference Transcript
Great. Good afternoon, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan and we're continuing the healthcare conference today with Legend Biotech. I'm joined on stage by the company's CEO, Ying Huang. And he's going to give a presentation on the business and then we're going to go into some Q&A. Anyone in the room, you can raise your hand to ask a question, someone will bring you a microphone, or if you have questions you want to submit on the portal, you can do that too.
So with that, let me pass it over to Ying.
Thank you, Jess, and I want to also thank JPMorgan for inviting Legend for this conference.
So with that, I'm going to give a very brief overview of the company's operation and then we'll go into Q&A with Jess and anyone, feel free to post questions from the room.
So first, standard disclaimer. We are a public trading company and we are going to make some
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |